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ABSTRACT 
Background:  It is unknown whether lesions in human tuberculosis (TB) are hypoxic or 
whether this influences disease pathology.  Human TB is characterized by extensive lung 
destruction driven by host MMPs, particularly collagenases such as MMP-1.   
Methods:  We investigated tissue hypoxia in five patients with PET imaging using the tracer 
[18F]-fluoromisonidazole ([18F]FMISO) and by immunohistochemistry.  We studied regulation 
of MMP secretion in primary human cell culture model systems in normoxia, hypoxia, 
chemical hypoxia and by siRNA inhibition. 
Results:  [18F]FMISO accumulated in regions of TB consolidation and around pulmonary 
cavities, demonstrating for the first time severe tissue hypoxia in man. Patlak analysis of 
dynamic PET data showed heterogeneous levels of hypoxia within and between patients.  In 
Mycobacterium tuberculosis (M.tb)-infected human macrophages, hypoxia (1% pO2) 
upregulated MMP-1 gene expression 170-fold, driving secretion and caseinolytic activity.  
Dimethyloxalyl glycine, a small molecule inhibitor which stabilises the transcription factor 
Hypoxia Inducible Factor (HIF)-1α, similarly upregulated MMP-1.  Hypoxia did not affect 
mycobacterial replication.  Hypoxia increased MMP-1 expression in primary respiratory 
epithelial cells via intercellular networks regulated by TB.   HIF-1α and NF-κB regulated 
increased MMP-1 activity in hypoxia. Furthermore, M.tb infection drove HIF-1α 
accumulation even in normoxia.  In human TB lung biopsies, epithelioid macrophages and 
multi-nucleate giant cells express HIF-1α.  HIF-1α blockade including by targeted siRNA 
inhibited TB-driven MMP-1 gene expression and secretion.   
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Conclusions:  Human TB lesions are severely hypoxic and M.tb drives HIF- 1α accumulation, 
synergistically increasing collagenase activity which will lead to lung destruction and 
cavitation  
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What is the key question? 
Is there functionally important hypoxia within human pulmonary TB lesions? 
What is the bottom line? 
Human TB lesions are severely hypoxic, and hypoxia exacerbates matrix metalloproteinase-
mediated inflammatory tissue destruction. 
Why read on? 
This study uses PET-CT to demonstrate for the first time that human lung lesions are 
severely hypoxic and demonstrates that hypoxia, at the level seen in humans, potently 
upregulates matrix metalloproteinase-1, a collagenase central to both cavity formation and 
spread of infection. 
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INTRODUCTION 
 
Mycobacterium tuberculosis (M.tb) is solely a pathogen of humans and infects one third of 
the global population, killing 1.5 million people each year [1].  Drug resistance in 
tuberculosis is increasing and there relatively few new drugs on the horizon.  Novel 
approaches to therapy require an understanding of the immune-pathology of TB.  Lung 
tissue destruction is a hallmark of pulmonary tuberculosis (TB) [2] and is key for 
transmission of infection.  Reduced tissue oxygenation has been noted in animal models of 
TB [3, 4], but hypoxia in human disease has not been investigated although may have a 
significant effect on the host response. The pathology of human TB is different to most 
animal models [2].  Furthermore, although extensive lung damage is found in TB, the effect 
of hypoxia on proinflammatory tissue destruction in TB has not been explored.   
MMPs are emerging as key proteases causing TB immunopathology.  Recent evidence 
implicates MMPs, particularly collagenases such as MMP-1, as key in driving tissue 
destruction during pulmonary TB [5-7].  Since MMPs may cause uncontrolled proteolytic 
destruction, MMP activity is tightly regulated at the transcriptional level, by cleavage of the 
proenzyme to an active form and by specific Tissue Inhibitors of Metalloproteinases (TIMPs) 
which negatively regulate protease activity. Regulation of MMPs by hypoxia in TB has not 
been studied.  
  
The cellular response to hypoxia is orchestrated by HIF-1, a heterodimeric transcription 
factor considered a master regulator of the host response to oxygen deprivation [8, 9].  In 
addition to regulating oxygen homeostasis, emerging evidence implicates HIF-1 in infectious 
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and inflammatory diseases [10].  HIF-1 is comprised of two subunits; oxygen-responsive HIF-
1α and constitutively expressed HIF-1β.  In normoxia, HIF-1α is hydroxylated by prolyl-4-
hydroxylase proteins (PHDs) [11, 12], allowing binding of the von Hipple-Lindau protein 
which targets HIF-1α for proteosomal degradation [13].  Under hypoxic conditions PHD 
activity declines, resulting in HIF-1α accumulation and HIF-1 heterodimer stabilization [14].  
This  HIF-1 complex binds  to promoter regions of hypoxia-inducible genes, upregulating  an 
array of genes including those involved in cell survival, angiogenesis, apoptosis, 
erythropoiesis, glucose metabolism and pH regulation [11].  HIF is responsive to a variety of 
stimuli, with the inflammatory transcription factor NF-κB being of particular importance in 
modulation of HIF expression [9].  The complex interaction between HIF-1α and NF-κB 
signifies a synergistic link between hypoxia and immune responses, indicating a potential 
role of hypoxia in driving TB immunopathology. 
In this study, we show for the first time that lesions in pulmonary TB infection are severely 
hypoxic in man. There is heterogeneity both within and between lesions in the extent of 
hypoxia.  In primary human monocyte-derived macrophages (MDMs) and normal human 
bronchial epithelial cells (NHBEs), hypoxia synergistically upregulates HIF-1α-dependent 
MMP-1 (collagenase) gene expression and secretion during M.tb infection.  In addition, M.tb 
stabilizes HIF-1α even in the absence of hypoxia.  HIF-1α accumulation is necessary for 
MMP-1 secretion and HIF-1α is highly expressed in macrophages in human TB granulomas.   
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METHODS 
Full methods are provided in the online supplement. 
Patient Recruitment  
Ethical approval for the study was obtained from East London and City Research Ethics 
Committee and Imperial College Healthcare Trust Joint Research Office, with further 
approval by the UK Administration of Radioactive Substances Advisory Committee (ARSAC). 
Patients were recruited from Imperial College Healthcare NHS Trust with a confirmed 
microbiological diagnosis of TB, either on acid-fast smear and / or M.tb culture. All patients 
had abnormal plain chest radiographs and had received less than 2 weeks of anti-TB 
therapy.  Informed consent was obtained from all study participants. 
18F-MISO PET-CT scans 
PET-CT scans were performed on a Siemens mCT (Siemens Medical, Erlangen, Germany) at 
the Department of Nuclear Medicine Charing Cross Hospital, Imperial College NHS Trust, 
London.  [18F]FMISO was synthesized in the Wolfson Brain Imaging Centre, University of 
Cambridge.  Patient scanning protocol and data analysis are described in the online 
supplement. 
M.tb culture 
M.tuberculosis H375v was cultured in Middlebrook 7H9 medium as previously described 
[15].  
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Cell Culture Experiments 
Monocyte-derived primary human macrophages were infected with M.tb H37Rv as 
described [15].  Primary human bronchial epithelial cells (Lonza, Slough, UK) were cultured 
and stimulated with conditioned media from Mtb-infected monocytes (CoMtb) and A549 
cells transiently transfected as described [16]. 
Hypoxia workstation 
A custom designed hypoxia workstation was commissioned for the biological safety level 3 
facility (Coy Laboratories, USA).   
Casein Zymography 
Casein zymography was performed as previously described [15].  
Real-time PCR 
Macrophages were lysed using Tri-Reagent (Sigma-Aldrich, Dorset, UK), and total RNA was 
extracted using PureLink RNA® Mini Kit (Invitrogen, Paisley, UK).  RNA was reverse 
transcribed using QuantiTect Reverse Transcriptase Kit (Qiagen, Manchester, UK). qPCR 
reactions were performed in an ABI Prism 7700 (Applied Biosystems, Paisley, UK).   
Measurement of MMP and TIMP concentrations 
Total MMP and TIMP secretion in cell culture supernatants was measured by ELISA (R&D 
Systems, Abdingdon, UK) or on the Luminex 200 platform using MMP Luminex multiplex 
array (R&D Systems, Abingdon, UK) according to the manufacturer’s instructions.  The 
minimum level of detection for MMP-1 was 10 pg/ml.  
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HIF-1α Western analysis 
Western blotting was performed using anti-HIF1α Ab (BD Biosiences, UK) and goat anti-
mouse IgG horseradish peroxidase (HRP)-conjugate secondary Ab (Jackson 
ImmunoResearch). Loading control was performed using the rabbit-anti β-actin Ab and goat 
anti-mouse IgG horseradish peroxidase (HRP)-conjugate secondary Ab (Jackson 
ImmunoResearch).  Luminescence was detected with the ECL system (Amersham, UK) 
according to manufacturer’s protocol. 
Confocal microscopy 
Primary human monocyte-derived macrophages were infected with M.tb H37RV in 
Permanox plastic chamber slides (Thermo Fisher Scientific Inc. UK).  MMP-1 staining was 
performed using anti-MMP-1 primary Ab (Abcam, UK) and goat anti-mouse secondary Ab 
(Abcam, UK) according to the manufacturers’ instructions.  Nuclei were visualized using 
DAPI.  
SiRNA  
MDMs were transfected using DharmaFECT 3 transfection reagent with either non-targeting 
control siRNA or HIF-1α siRNA smartpool (Dharmacon, FisherScientific, Loughborough, UK), 
according to the supplier’s instructions.   
Immunohistochemistry 
HIF-1α immunohistochemistry was performed on formalin-fixed, paraffin-embedded lung 
biopsies from six patients with culture-proved M.tb infection and six non-infected control 
samples.  Immunohistochemistry staining was performed using Bond III fully automated 
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staining system with the Bond Polymer Refine Detection system and associated reagents 
(Leica Microsystems, Newcastle-Upon-Tyne, UK). HIF-1α was detected using HIF1-α 
antibody (Abcam AB1).   
Statistics 
Statistical analysis was performed using GraphPad PRISM 6.  Data was analyzed with 
Kruskal-Wallis for comparison between 3 or more groups and Dunn’s test for pairwise 
comparisons.  A P value of 0.05 was considered significant.  For all experiments, bars 
represent mean values ± SD from a minimum of two independent experiments performed in 
triplicate.  
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RESULTS 
Regions of severe hypoxia are present in human pulmonary TB lesions  
To investigate hypoxia in TB patients, we performed PET-CT scans in patients who had acid-
fast bacilli identified in respiratory specimens that were subsequently culture confirmed to 
be M.tb (Patient demographics and microbiology are in Supplementary table 1).  The 
average duration of pulmonary symptoms was 2.4 months and all patients were HIV 
negative (Patient laboratory data are presented in Supplementary table 2).  To investigate 
hypoxia, we used the hypoxia-specific tracer 18F-fluoromisonidazole ([18F]FMISO), which has  
been used to study tumour biology [17].  [18F]FMISO is selectively trapped in severely 
hypoxic regions (pO2<10mmHg) [18-20].  PET-CT scans in 5 patients demonstrated extensive 
uptake of [18F]FMISO in radiologically abnormal areas of the lung, as assessed by [18F]FMISO 
target-to-background (TBR) (Figure 1A), with the lateral muscle used as a background 
representing normoxic tissue.  TBR values significantly greater than unity were found in one 
or more lesions in all patients (Figure 1B). 
To provide a more specific measure of hypoxia than TBR, Patlak Ki mapping was applied, 
which demonstrated the presence of severe hypoxia within areas of consolidation and in the 
regions immediately surrounding pulmonary cavities (Figure 2A and Supplementary Table 
3). All patients had Ki values greater than a hypoxia threshold in at least one region of 
interest (Figure 2B).  Heterogeneous levels of hypoxia were seen within patients with the 
exception of Patient 2, who demonstrated evidence of severe hypoxia in all ROIs.  Finally, 
time-activity curves demonstrated significantly higher levels of [18F]FMISO within ROIs 
compared to peripheral blood (Figure 2C).  Together, these data demonstrate for the first 
time the presence of severe hypoxia within TB lesions in man.   
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Hypoxia increases M.tb-driven MMP-1 expression in human macrophages 
Next, the effect of hypoxia (1% pO2) on gene expression and secretion of MMP-1 was 
investigated.  Hypoxia significantly increased MMP-1 gene expression in M.tb-infected 
human MDMs compared to infection in normoxia (21% pO2), resulting in a 170-fold  
increase in MMP-1 mRNA accumulation at 24h (Figure 3A, p<0.0001 by Kruskal-Wallis test).  
Increased MMP-1 accumulation under hypoxic conditions in M.tb-infected MDMs was 
confirmed by confocal microscopy (Figure 3B).  In both normoxia and hypoxia, M.tb was a 
more potent stimulus to MMP-1 secretion than LPS (Figure 3C, p<0.05 and p<0.01 
respectively).  Casein zymography demonstrated that the increased MMP-1 secretion in 
hypoxia was proteolytically active (Figure 3D).   
Next, we used dimethyloxalyl glycine (DMOG) to block prolyl hydroxylase activity, thereby 
stabilizing HIF-1α and activating the HIF-1 pathway.  Consistent with findings in 1% pO2, 
DMOG significantly increased MMP-1 secretion in M.tb-infected macrophages, causing a 
dose-dependent increase in secretion and caseinolytic activity (Figure 3E).  Hypoxia caused 
no difference in M.tb colony forming units 72 hrs post infection (data not shown), 
demonstrating that intracellular replication of M.tb was not altered.   
 
Hypoxia increases M.tb-dependent MMP-1 expression in respiratory epithelial cells  
Next, we investigated the effect of hypoxia on respiratory epithelial cell MMP-1 secretion, 
as stromal cell networks are important sources of MMPs in TB [16].  Conditioned media 
from M.tb-infected monocytes (CoMTb) stimulation of primary NHBEs in hypoxia (5% and 
1% pO2) increased MMP-1 secretion (Figure 4A; p<0.05).  LDH release assay showed that 
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hypoxia did not increase cell cytotoxicity (Supplementary Figure 1). Such MMP-1 secretion is 
potentially open to modification by small molecules, since stabilization of HIF-1α by DMOG 
also increased MMP-1 secretion in CoMTb-stimulated NHBEs in a dose-dependent manner 
(Figure 4B, p<0.01).  In addition, 0.25mM DMOG increased NHBE cell MMP-9 secretion and 
proteolytic activity on gelatin zymography (Supplementary Figure 2).  
  
There were similar findings in the A549 respiratory epithelial cell line (Supplementary Figure 
3).    In silico analysis of the MMP-1 promoter sequence demonstrated numerous putative 
hypoxia response elements (HREs) which are HIF-1 binding sites, as well as known NF-κB and 
AP-1 binding sites (Figure 4C).  A549 cells were transiently transfected with either full length 
MMP-1 promoter-reporter genes or truncation constructs and stimulated with CoMTb in 
the presence or absence of hypoxia.  In normoxia, deletions upstream of -2941 resulted in 
increased MMP-1 promoter activity indicating the presence of inhibitory elements (Figure 
4D).  Deletions downstream of -2941bp from the transcriptional start site reduced MMP-1 
promoter activity.  The presence of hypoxia resulted in increased MMP-1 promoter activity, 
compared to normoxia, in deletion constructs upstream of -1551. To investigate whether 
NF-κB regulated MMP-1 expression in hypoxia, IKK-β activity was inhibited by SC-514.  IKK-β 
inhibition significantly decreased MMP-1 secretion in a dose-dependent manner in 
normoxia and this effect was more pronounced in hypoxia (Figure 4E).  Site-directed 
mutagenesis of the NF-κB binding site between -2878 and -2886 bp in the MMP-1 promoter  
reduced MMP-1 promoter activity observed in hypoxia (Figure 4H; p<0.01 by Kruskal-
Wallis).   
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M.tb stabilizes HIF-1α, driving MMP-1 expression, and HIF-1α is expressed in TB patient 
granulomas   
Next, we investigated whether M.tb directly affected HIF-1 accumulation independently of 
the stimulus from hypoxia. In respiratory epithelial cells, DMOG and CoMTb-stimulation of 
A549 cells independently upregulated HIF-1α.  Concurrent exposure to DMOG and 
stimulation by CoMTb resulted in maximal accumulation of HIF-1α (Figure 5A).   In human 
MDMs, M.tb infection in normoxia induced stabilization and accumulation of HIF-1α peaking 
at 24 hours (Figure 5B).  Hypoxia and M.tb infection synergistically drove prolonged and 
increased HIF-1α accumulation in MDMs compared to cells exposed to either stimulus 
alone, with HIF-1α accumulation detectable from 4 hours after infection (Figure 5C).  M.tb 
infection did not induce HIF-2 accumulation either in normoxia or hypoxia (data not shown).   
To investigate whether HIF-1α regulated MMP-1 expression during TB infection, we 
inhibited the activity of HIF-1α in normoxia and hypoxia.  The inhibitor LW6 caused a trend 
to decreased M.tb-driven MMP-1 secretion in human MDMs in normoxia, but in hypoxia 
there was a significant dose-dependent decrease in MMP-1 secretion (Figure 5D; p<0.05).  
To confirm this observation, further studies were performed with HIF-1α siRNA.  Western 
blot analysis demonstrated that targeted but not non-targeting siRNA decreased HIF-1α 
protein in M.tb infected MDMs in normoxia and hypoxia (Figure 6A).  HIF-1α siRNA 
decreased MMP-1 mRNA accumulation (Figure 6B; p<0.0001) and protein secretion (Figure 
6C) in both normoxic and hypoxic conditions (p<0.05).  Non-targeted siRNA did not suppress 
MMP-1 gene expression or protein secretion.   
To investigate the relevance of HIF-1α to TB granulomas in patients, we performed 
immunohistochemical analysis of lung biopsy specimens from patients with a confirmed 
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diagnosis of TB.  Epithelioid macrophages and Langerhans giant cells were immunoreactive 
for HIF-1α staining within TB granulomas (Figure 6D i,ii) compared to uninfected control 
lung tissue (Figure 6D iii), demonstrating that TB infection causes HIF-1α accumulation.   
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DISCUSSION 
In this first detailed study of hypoxia in human tuberculosis, we demonstrate the presence 
of severe hypoxia within areas of lung consolidation and around pulmonary cavities in 
human TB.  Hypoxia increases gene expression and secretion of MMP-1, a key collagenase 
that causes tissue destruction and immunopathology in pulmonary TB.  In addition, M.tb 
infection directly drives HIF-1α accumulation, which is further increased in hypoxia to 
synergistically activate immunopathogenic signalling pathways.   
 
We demonstrated hypoxia in human TB using [18F]FMISO PET-CT scanning for the first time 
in patients with an infectious disease. Hypoxia has not previously been found in man 
although reported in animal models of TB, all of which have somewhat different pathology 
to human disease [3, 4].  Until now, the investigation of hypoxia and TB has focussed 
primarily on pathogen responses to oxygen restriction, controlled by the two-component 
regulation system dosR/dosS (or dosR regulon) [21, 22].    Direct assessment of hypoxia in 
vivo typically involves the utilization of polagraphic oxygen electrodes which can provide 
absolute measurements of tissue oxygenation at the sampling location.  However, this 
procedure is technically demanding and suffers from a number of limitations including 
invasiveness, high susceptibility to sampling errors and the fact that only easily accessible 
locations can be interrogated [23].  [18F]FMISO PET-CT scans define regions of hypoxia 
without the need for invasive probes, as previously shown in tumour biology [24] and 
cerebral ischaemia [25].  Since high tracer uptake, as quantified by standardized uptake 
value (SUV) or TBR, may represent high tracer delivery to a region of interest rather than 
tracer trapping under hypoxic conditions, we determined the influx rate of [18F]FMISO into 
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the trapped tissue compartment (Ki) so as to more specifically identify tissue hypoxia.  The 
maximum TB lesion Ki value (0.005 min
-1) is equal to the highest Ki value in an [
18F]FMISO 
study of head and neck cancer by Wang et al [26], which puts the degree of hypoxia in this 
study into context.  Our data reveals that heterogeneity exists both within individual TB 
lesions and between lesions, consistent with the concept of multiple TB microenvironments 
existing within a single patient. 
 
The finding of hypoxia within lung lesions directed our cellular experiments.  MMP-1 gene 
expression and secretion were significantly increased in M.tb-infected human macrophages 
in hypoxia compared to normoxia and MMP-1 was functionally active.  However, hypoxia 
had no effect on mycobacterial growth in our experiments. Diverse lines of investigation are 
implicating MMP-1 as a key protease in TB pathology.  MMP-1 causes collagen destruction 
in M.tb-infected transgenic mice [6] and M.tb infection upregulates MMP-1 more potently 
than M.bovis BCG in human macrophages [15]. In pre-sensitized rabbits, MMP-1 has been 
shown to have a causal role in pulmonary cavitation [27].  Specifically, the development of 
cavities within areas of dense consolidation has been associated with MMP-1/TIMP 
imbalance and high intracavitary bacterial burden.  In human TB granulomas, MMP-1 
expression is up-regulated 606-fold compared to uninfected lung [28].  Similarly, MMP-1 
was the most potently upregulated gene in macrophages from patients who developed TB 
compared with those with latent disease [29].  The effect of hypoxia was mimicked by 
chemically targeting the pathway with DMOG, which suggests that it may be possible to 
therapeutically manipulate the excess inflammatory response in TB using small molecules. 
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Hypoxia-dependent, monocyte driven up-regulation of MMP-1 gene expression in human 
respiratory epithelial cells required the transcription factor NF-κB.  NF-κB and HIF-1α 
interact to regulate innate immunity and inflammation [9, 10]. NF-κB critically regulates 
MMP activity in TB infection of the central nervous system [30], but has not been 
investigated in the context of hypoxia-driven MMP expression in TB infection.   NF-κB is 
both directly affected by hypoxia and modulates HIF-1α expression as well as being 
regulated by prolyl hydroxylases [31].  The precise nature of the interaction between HIF-
1α, prolyl hydroxylases and NF-κB in TB is currently being investigated by our group.   
 
M.tb caused significant accumulation of HIF-1α in direct infection and via a networking 
effect even in the absence of hypoxia, with a synergistic increase in HIF-1α expression in 
hypoxia or following treatment with DMOG. To our knowledge, this is the first time that 
hypoxia-independent HIF-1α stabilization has been observed in any mycobacterial infection, 
although similar effects have been reported in other infections [32, 33].  Interestingly, 
recent gene expression profiling in peripheral whole blood demonstrated significant up-
regulation of HIF-1α gene expression in TB patients compared to controls [34].  Our findings 
are consistent with the demonstration of activation of HIF-1α signalling pathways following 
infection in a zebrafish model of TB infection [35].  We showed expression of HIF-1α within 
TB granulomas, localizing the activity to epithelioid macrophages and multi-nucleate giant 
cells, which we have previously shown are key in secretion of several MMPs [15].  We 
demonstrate that HIF-1α regulates MMP-1 expression in TB.  Since the chemical inhibitor 
LW6 can lack specificity we used targeted siRNA to confirm this finding.  Consistent with our 
data in TB, hypoxia and HIF-1α regulate MMP-driven tissue destruction in hypoxic 
fibroblasts within rheumatoid synovium [36].  
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In summary, we show for the first time that human TB lesions are severely hypoxic.  Hypoxia 
increases MMP-1 gene expression and secretion during M.tb infection, and M.tb infection 
independently increases HIF-1α activity even under conditions of normoxia.  Taken 
together, our data suggests the M.tb drives a HIF-1α-dependent proinflammatory tissue 
destructive cascade that may lead to cavitation and promote disease transmission, 
representing a potential future therapeutic target in the era of increasing drug resistant TB.  
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FIGURE LEGENDS 
Figure 1.  [18F]FMISO PET-CT demonstrates increased tracer uptake within TB lesions 
(A)  [18F]FMISO PET-CT images.  Transverse, coronal and sagittal slices through the 
[18F]FMISO target-to-background (TBR) and CT images of patient 2. Top row, CT images 
show consolidation and a pulmonary cavity in the right upper lobe with a smaller, non-
cavitating lesion in the left lung.  Middle row, [18F]FMISO TBR map demonstrates intense 
uptake of tracer in the right upper lobe lesion and the liver, the site of metabolism of 
[18F]FMISO.  Bottom row, co-registered CT and TBR images.  (B)  Target-to-background (TBR) 
values greater than unity were found for at least one lesion in all patients (each individual 
bar represents one region of interest, ROI).  
 
Figure 2.  Severe hypoxia is present within human pulmonary TB lesions 
(A) Patlak Ki images from dynamic PET-CT scanning for Patient 2 demonstrate intense 
retention of [18F]FMISO in the right upper lobe of the lung (middle row).  Co-registered PET-
CT images (bottom row) confirm localization of hypoxia to the region of the right upper lobe 
cavity.  (B) Regional Ki values demonstrate heterogenous trapping of [
18F]FMISO within and 
between patients.  The hypoxia threshold (0.00037 min-1) was determined from the mean + 
3 standard deviations of the Ki values in the normoxic lateral muscle background regions 
across the patient group.  (C) Time-activity measurements of five ROIs from patient 3 
demonstrate high tissue levels compared to peripheral blood values. 
   
Figure 3.   Hypoxia increases M.tb-driven MMP-1 expression and secretion by human 
monocyte-derived macrophages (MDMs).   
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(A)  Hypoxia (1% pO2) increases MMP-1 gene expression in primary human MDMs infected 
with M.tb at 24 hours.    (B)  Hypoxia increases intracellular MMP-1 accumulation on 
confocal microscopy at 72hrs in MDMs infected with M.tb (MOI=1) compared to normoxia 
or control uninfected cells. (C) Mtb infection increases MMP-1 secretion by infected MDMs 
greater than LPS (100ng/ml) in both normoxia and hypoxia analyzed 72h after infection.  (D)  
MMP-1 activity is increased in M.tb-infected but not control human macrophages analyzed 
by casein zymography, and hypoxia further increases caseinolytic activity. (E) Stabilization of 
HIF-1α by DMOG (range 0.05-0.5mM) significantly increases MMP-1 secretion analyzed by 
ELISA and proteolytic activity measured by zymography in a dose-dependent manner. N = 
21% O2; 5% CO2, H = 1% O2; 5% CO2. ****p< 0.0001, ***p< 0.001, **p< 0.01, *p< 0.05. 
 
Figure 4.  Hypoxia upregulates MMP-1 in human respiratory epithelial cells.   
(A)  Hypoxia increases MMP-1 secretion from NHBE cells stimulated with control medium or 
CoMTb incubated in 21%, 5% or 1% oxygen. (B) DMOG (range 0.1-0.25mM) drives dose-
dependent MMP-1 secretion from CoMTb-stimulated NHBE cells.  (C) In silico analysis of the 
MMP-1 promoter reveals putative hypoxic response element (HRE) binding sites as well as 
consensus NF-κB and AP-1 binding sites.  (D)  Relative luminescence following transfection 
of A549 respiratory epithelial cells with either WT-MMP-1 promoter or a series of MMP-1 
promoter deletion constructs in normoxia (solid bars) or hypoxia (shaded bars).  The effect 
of hypoxia in increasing promoter activity is absent in constructs -1551, -1194 and -517. (E) 
IKKβ inhibition in hypoxia with SC-514 in CoMTb stimulated cells resulted in a dose-
dependent decrease in MMP-1 secretion.  (F)  Site-directed mutagenesis of the NF-κB 
binding site at -2878 to -2886bp decreases MMP-1 promoter activity in response to CoMTb 
in normoxia (solid bars) or hypoxia (shaded bars).  **p< 0.01, * p< 0.05. 
25 
 
 
Figure 5.  M.tb infection drives HIF-1α accumulation in normoxia 
(A) In A549 cells, CoMTb stimulation and DMOG (0.25mM) results in early HIF-1α 
stabilization.  Pre-incubating A549 cells with DMOG (0.25mM) and subsequent stimulation 
with CoMTb markedly increases HIF-1α accumulation, peaking at 6 hrs. (B) M.tb infection 
increases HIF-1α accumulation and stabilization in normoxia in primary human MDMs, 
peaking at 24hrs.  (C)  Combined infection with M.tb and exposure to hypoxia causes greater 
HIF-1α accumulation than either stimulus alone, peaking at 4hrs and persisting until 24hr.  
(D) Inhibition of HIF-1α by LW6 (range 50-100µM) results in decreased MMP-1 secretion in 
M.tb-infected MDMs in hypoxia (hatched bars).   **p< 0.01. 
 
Figure 6.  HIF-1α is necessary for MMP-1 gene expression and secretion during M.tb 
infection. 
(A) HIF-1α western blot at 24hrs demonstrates suppression of HIF-1α protein by HIF-1α 
siRNA in MDMs in both normoxia and hypoxia, with no knockdown observed with non-
targeting (NT) siRNA.  (B) HIF-1α siRNA decreases MMP-1 gene expression at 24hrs in M.tb 
infected MDMs incubated in hypoxia.  (C)  HIF-1α siRNA causes a significant decrease in 
MMP-1 secretion at 48hrs under conditions of normoxia (solid bars) and hypoxia (hatched 
bars).  No significant change in MMP-1 gene expression or secretion is seen with non-
targeting siRNA. (D) Lung biopsies from patients with pulmonary TB (i, ii) are 
immunoreactive for HIF-1α compared with uninfected control biopsies (iii).  HIF-1α staining 
is pronounced within macrophages and multinucleated giant cells (arrow, ii).  Scale bars, 
100 µm. ****p< 0.0001, *p< 0.05. 
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Methods 
18F-MISO PET-CT scans 
PET-CT scans were performed on a Siemens mCT (Siemens Medical, Erlangen, Germany) at 
the Department of Nuclear Medicine Charing Cross Hospital, Imperial College NHS Trust, 
London.  [18F]FMISO was synthesized in the Wolfson Brain Imaging Centre, Cambridge 
University.  Patients received 406 ±6 MBq [18F]FMISO intravenously followed by a 90 minute 
uptake period to promote contrast between normoxic and hypoxic tissue on tissue-to-
background (TBR) images, and also to allow the free [18F]FMISO concentration in tissue to 
reach equilibrium with that in blood, a pre-requisite for Patlak plot determination of influx 
rate (Ki) [1]. Immediately following a low dose CT scan for attenuation correction, patients 
underwent a 45 minute single bed position PET scan acquired in list mode.  As Patlak 
analysis requires knowledge of the input function to the tissue, three venous blood samples 
(90, 135 and 145 minutes post-injection) were taken in order to scale to a population-based 
[18F]FMISO arterial plasma function.  The latter was produced from 6 controls scanned at 
The Wolfson Brain Imaging Centre, University of Cambridge as part of a study on stroke (PI: 
Prof J-C Baron), which included late venous sampling as part of the study protocol. 
 
[18F]FMISO PET-CT data analysis 
List mode PET data were reconstructed into 9x5min frames using OSEM [2] (8 subsets, 4 
iterations, 5mm FWHM 3D Gaussian post-smoothing filter) into a 168x168x74 array with 
voxel dimensions 4.07 x 4.07 x 3.00mm.  Corrections were applied for randoms, dead time, 
normalization, scatter, attenuation, sensitivity and radioactive decay.  To reduce the impact 
of patient motion during PET acquisition, the last 8 frames of the dynamic PET image series 
were non-rigidly registered to the first frame using symmetric normalization (SyN) with 
mutual information as the similarity metric [3].  All PET frames were then registered to CT 
using affine transformation.  The last three of the registered frames (120-135mins post 
injection) were converted to a TBR image through normalization with the radioactivity 
concentration in a bilateral lateral muscle region assumed to represent normoxic tissue.  All 
9 frames were used to produce a Ki map using Patlak plot analysis.  Regions of interest (ROI) 
were defined on the TBR images and ROI values were determined by placing the ROIs on the 
TBR and Ki maps.  
 
M.tb culture 
M.tuberculosis H375v was cultured in Middlebrook 7H9 medium supplemented with 10% 
OADC enrichment medium (BD Biosciences, Oxford, UK), 0.2% glycerol and 0.02% Tween 80.  
Cultured cells were infected with M.tb at mid-logarithmic growth at an optical density of 0.6 
(Biowave cell density meter, WPA, Cambridge, UK).  To count intracellular bacilli, infected 
MDMs were lysed with 0.1% Triton-X.  Aliquots of cell lysates were serially diluted 10-fold in 
7H9 liquid and 4 dilutions of each sample were plated on 7H11 agar and incubated for 14 
days befoe determining the number of CFU. 
 
Monocyte Purification and Maturation 
Monocytes were isolated from single donor leucocyte cones (National Blood Transfusion 
Service, London, UK) by density gradient centrifugation (Amersham Biosciences) and re-
suspended in RPMI.   Monocytes were purified by adhesion for 1 hour followed by washing 
6 times in HBSS to remove non-adherent cells.  Monocytes were matured for 4 days in 
100ng/ml M-CSF and then rested for 1 day in RPMI containing no M-CSF.  The resultant 
monocyte-derived macrophages (MDMs) were infected with M.tuberculosis H37RV at an 
MOI of 1.  MMP gene expression was analyzed at 24 hours and MMP secretion measured at 
3 days after infection.  Conditioned media from M.tb infected monocytes (CoMTb) was 
produced by infecting monocytes at a multiplicity of infection (MOI) of 1.  After 24 hours, 
cell culture medium was harvested, centrifuged at 13,000rpm for 5 minutes and filtered to 
remove infectious material using a 0.2μm Anopore filter (Whatman, UK) [4].   
 
Epithelial cell culture 
Normal human bronchial epithelial cells (NHBE) (Lonza, Basel, Switzerland) and the human 
type II alveolar A549 cell line were acquired as cryopreserved cells and regenerated 
according to the manufacturers’ instructions.   A549 cells were maintained in RMPI 1640 
with 10% FCS, 2mM glutamine, and 10mg/ml ampicillin.  Experiments were performed on 
cells between passage 8-16 and unless otherwise stated, cell culture supernatants were 
harvested at 72 hours and MMPs analysed by ELISA or Luminex array.  Cell viability was 
assessed by trypan blue exclusion.  Chemical inhibition experiments were performed using 
dimethyloxalylglycine (DMOG conc. range 0.05-0.5mM) (Inochem, Carnforth, UK), helenalin 
SC-514 (conc. range 1-100µM) and 3-(2-(4-Adamantan-1-yl-phenoxy)-acetylamino)-4-
hydroxybenzoic acid methyl ester, LW6 (conc. range 50-100µM) (all MerckMillipore, 
Darmstatd, Germany).  All inhibitors were dissolved in DMSO according to manufacturers 
instructions. 
Hypoxia workstation 
A custom designed hypoxia workstation was commissioned for the biological safety level 3 
facility (Coy Laboratories, USA).  The workstation comprised a sealed environment with an 
inbuilt humidified incubator accessed by air-tight gloves.  Materials and reagents were 
passed in and out of the workstation via a sealed airlock, such that the atmosphere 
remained constant at all times.  Temperature and CO2 were maintained at 37
0C and 5% 
respectively and O2 levels (by N2 displacement) adjusted according to the experimental 
requirements.  All parameters were monitored by digital sensors throughout and 
adjustments made automatically.  In experiments comparing multiple oxygen levels, a 
hypoxic incubator was also used for 5% O2 (Galaxy 14S, New Brunswick, UK) 
 
Casein Zymography 
To analyze MMP-1 activity, samples were electrophoresed on 0.05% casein gels (Invitrogen) 
and incubated in collagenase buffer at 37oC for 48h.  All gels were run with a 5ng 
recombinant MMP-1 (Calbiochem, Merck Biosciences, UK) to standardise between gels.  
Caseinolytic activity was revealed by Coomassie blue staining (Pharmacia) for one hour 
followed by destain in methanol: acetic acid: water [5]. 
Real-time PCR 
Macrophages were lysed using Tri-Reagent (Sigma-Aldrich, Dorset, UK), and total RNA was 
extracted using PureLink RNA® Mini Kit (Invitrogen, Paisley, UK).  1µg RNA was reverse 
transcribed using QuantiTect Reverse Transcriptase Kit (Qiagen, Manchester, UK). qPCR 
reactions were performed in an ABI Prism 7700 (Applied Biosystems, Paisley, UK).  MMP-1 
cycle thresholds were quantified by comparison to an MMP-1 standard curve generated 
using known MMP-1 concentrations generated from a plasmid standard and then 
standardised to 18S rRNA.  HIF-1α mRNA samples were analysed using the comparative 
threshold method. The Ct values of both calibrator and samples were normalized to 18S 
rRNA. 
 
Measurement of MMP and TIMP concentrations 
Total MMP and TIMP secretion in cell culture supernatants was measured by ELISA (R&D 
Systems, Abdingdon, UK) or on the Luminex 200 platform using MMP Luminex multiplex 
array (R&D Systems, Abingdon, UK) according to the manufacturer’s instructions.  The 
minimum level of detection for MMP-1 was 10 pg/ml.  
 
HIF-1α Western analysis 
Cells were washed 3 times in sterile PBS and then lysed in SDS sample buffer (62.5mM Tris, 
2% SDS, 10% glycerol, 50mM DDT, 0.01% bromophenol blue).  For macrophages directly 
infected with M.tb H37RV, samples were sterile filtered through a 0.2μm Anopore filter 
(Whatman, UK). After heat-denaturation, samples were separated by electrical gradient on 
a NuPAGE Bis-Tris 4-12% gel (Invitrogen, Paisley, UK), electro-transferred to a nitrocellulose 
membrane (Amersham, UK) and blocked with 5% milk protein/0.1% Tween-20. The 
membrane was probed with anti-HIF1α Ab (1:1,000 dilution) (BD Biosiences, UK) overnight, 
washed, and incubated with goat anti-mouse IgG horseradish peroxidase (HRP)-conjugate 
secondary Ab (1:1,000 dilution, Jackson ImmunoResearch). Loading control was performed 
using the rabbit-anti β-actin Ab (1:5,000 dilution) and goat anti-mouse IgG horseradish 
peroxidase (HRP)-conjugate secondary Ab (1:5,000 dilution, Jackson ImmunoResearch).  
Luminescence was detected with the ECL system (Amersham, UK) according to 
manufacturer’s protocol. 
 
Confocal microscopy 
Primary human monocytes were matured to macrophages in 4-well Permanox plastic 
chamber slides (Thermo Fisher Scientific Inc. UK).  Cells were fixed for 3 days following 
infection with 4% paraformaldehyde in PBS for 30 minutes. Cells were permeabilized with 
0.5% saponin and blocked with 1% BSA for 1 hr.  Cells were incubated with anti-MMP-1 
primary Ab (1:200, Abcam, UK) overnight, washed and incubated with goat anti-mouse 
secondary Ab (1:100, Abcam, UK) and labelled with FITC for 2 hrs.  Nuclei were visualized 
using DAPI.  The images were scanned under an x60 oil immersion objective and to avoid 
bleed-through effects, each dye was scanned independently by a Leica TCS SP5 equipped 
with an argon-krypton mixed gas laser. Image analysis was with Leica confocal software 
(Leica Microsystems, Germany) and Image J v1.48a.  
 
Promoter-reporter assay 
A549 cells were transfected with either wild-type, truncation or deletion constructs of the 
MMP-1 promoter DNA inserted into the firefly luciferase expression plasmid pGL2-basic (gift 
from Dr. I. Clarke, University of East Anglia, U.K.) and control reporter plasmid, pRL-TK, 
constitutively expressing Renilla luciferase activity, with FuGene 6 (Roche) [6].  Cells were 
stimulated with CoMTb in the presence or absence of hypoxia then lysed after 24 h.  
Luciferase activity was measured using the Dual-Luciferase Reporter Assay System 
(Promega, Southampton, UK) analyzed with the Bio-Orbit 1253 luminometer (Labtech 
International).  Renilla luciferase activity was used to normalize firefly activity to control for 
transfection efficiency. 
 
siRNA  
Monocytes were isolated and differentiated into MDMs.  MDMs were transfected using 
DharmaFECT 3 transfection reagent with either non-targeting control siRNA or HIF-1α siRNA 
smartpool (Dharmacon, FisherScientific, Loughborough, UK), according to the supplier’s 
instructions.  Transfection medium was replaced with RPMI at 8hrs and cells allowed to rest 
for 16hrs, at which time the MDMs were infected with M.tb H37Rv (MOI= 1).  Cell culture 
supernatant and cell lysates were harvested for HIF-1α and MMP-1 mRNA and protein 
secretion analyses.  To access transfection efficiency, MDMs were also transfected with 
25nM FAM conjugated non-targeting control siRNA, detached from the plates with cell 
dissociation buffer (Gibco, Invitrogen) and analysed by flow cytometry (FACSCalibur, BD 
Biosciences).  
Immunohistochemistry 
HIF-1α immunohistochemistry was performed on formalin-fixed, paraffin-embedded lung 
biopsies from six patients with culture-proved M.tb infection and six non-infected control 
samples.  Immunohistochemistry staining was performed using Bond III fully automated 
staining system with the Bond Polymer Refine Detection system and associated reagents 
(Leica Microsystems, Newcastle-Upon-Tyne, UK).  Antigen retrieval was carried out using 
Epitope retrieval pH 6 (ER1) at 100°C for 30mins.  The antibody HIF1-α (Abcam AB1) was 
applied for 30mins at a dilution of 1/500.  The detection system uses DAB as chromogen and 
section were counterstained with haematoxylin.   
 
Statistics 
Statistical analysis was performed using GraphPad PRISM 6.  Data was analyzed with one-
way ANOVA and Tukey’s post-test performed to account for multiple comparison of 
variables.  A P value of 0.05 was considered significant.  For all experiments, bars represent 
mean values of 3 samples ± SD.  All graphs are representative of at least duplicate 
experiments.  
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Patient 1 1P 
 
Patient 2 
 
Patient 3 
 
Patient 4 
 
Patient 5 
 
Sex (M/F) 
 
M 
 
F 
 
F 
 
F 
 
F 
 
Age (years) 49 22 31 37 62 
 
Country of origin Romania Mongolia Nepal Philippines Morocco 
 
Height (cm) 178 160 153 157 156 
Weight (kg) 64 53.2 44.9 45.3 48 
 
Duration of symptoms  6 months 3 months 1 month 1 month 1 month 
 
Symptoms 
Cough 
Weight loss 
Fever 
Haemoptysis 
GI symptoms 
Lethargy 
 
+ 
+ 
+ 
+ 
- 
- 
 
+ 
- 
+ 
- 
- 
- 
 
+ 
+ 
+ 
- 
+ 
- 
 
+ 
+ 
+ 
- 
- 
- 
 
+ 
- 
+ 
- 
- 
+ 
 
Smoking status  Current 
30 pack years 
 
Never Never Never Never 
CXR  
Consolidation 
Cavitation 
Fibrosis 
 
+ 
+ 
- 
 
+ 
+ 
- 
 
+ 
- 
+ 
 
+ 
+ 
- 
 
+ 
+ 
- 
 
Sputum smear AFB +++ AFB +++ AFB + AFB + AFB +++ 
 
 
Days to M.tb culture 
positivity 
 
Antibiotic sensitivity 
 
3 days 
 
 
Fully sensitive 
 
7 days 
 
 
Resistant 
isoniazid + 
streptomycin 
 
26 days 
 
 
Fully 
sensitive 
 
7 days 
 
 
Resistant 
rifampicin, 
isoniazid + 
prothionomide 
 
 
5 days 
 
 
Fully sensitive 
 
Supplementary Table 1.  Patient demographics, chest radiograph and microbiology results 
 
  
  
    Patient 1t 1 
 
Patient 2 
 
Patient 3 
 
Patient 4 
 
Patient 5 
 
Haematology 
Hb (g/dl) 
WCC (x109g/l) 
Neutrophil (x109g/l) 
 
Biochemistry 
Na (mmol/l) 
K+ (mmol/l) 
Urea (mmol/l) 
Cr (µmol/l) 
 
CRP (mg/l) 
 
Liver function 
Bilirubin (µmol/l) 
ALT (IU/l) 
ALP (IU/l) 
Total protein (g/l) 
Albumin (g/l) 
 
HIV status 
 
Vitamin D (nmol/l) 
 
 
10.8 
7.5 
6.0 
 
 
129 
4.0 
3.5 
52 
 
189 
 
 
10 
39 
135 
62 
39 
 
Negative 
 
26.0 
 
 
 
 
10.2 
7.7 
4.4 
 
 
141 
4.1 
3.5 
53 
 
10.6 
 
 
n/a 
n/a 
n/a 
n/a 
n/a 
 
Negative 
 
28.6 
 
 
10.1 
10.4 
7.3 
 
 
134 
4.8 
2.4 
55 
 
150 
 
 
6 
13 
95 
70 
27 
 
Negative 
 
24.3 
 
 
 
12.7 
16.4 
12.8 
 
 
132 
4.0 
3.1 
65 
 
69 
 
 
11 
29 
114 
72 
24 
 
Negative 
 
25.9 
 
 
10.4 
10.7 
8.7 
 
 
132 
4.0 
8.1 
97 
 
312 
 
 
12 
<6 
113 
75 
49 
 
Negative 
 
  14.9 
      
      
Supplementary Table 2.  Blood analysis at time of presentation   n/a, not available  
  
Supplementary Table 3.  Appearance on CT and binary hypoxic scale for each lesion 
examined. 
Patient number Lesion number CT appearance Hypoxic* 
1 1 Consolidation - 
2 Consolidation + 
3 Consolidation - 
4 Consolidation - 
2 1 Consolidation + 
2 Consolidation + 
3 Cavity wall + 
4 Consolidation + 
3 1 Consolidation + 
2 Consolidation + 
3 Consolidation + 
4 Consolidation + 
5 Consolidation - 
6 Consolidation - 
7 Consolidation + 
4 1 Cavity wall + 
2 Cavity wall + 
5 1 Cavity wall - 
2 Cavity wall - 
3 Consolidation + 
4 Consolidation + 
5 Consolidation - 
*The binary hypoxic scale denotes whether the lesion ROI Ki value is above a hypoxia 
threshold (0.00037 min-1) determined from the mean + 3SD of the Ki values within the 
lateral muscle background ROIs, assumed to represent normoxic tissue. 
  
Figure Legends Supplementary figures 
 
Figure S1. Hypoxia does not cause cytotoxicity in NHBE cells 
NHBE cells were stimulated with CoMTb and incubated in normoxia or hypoxia (1% or 5% 
pO2; 5% CO2).  Supernatant were harvested at 72 hrs.   Hypoxia did not cause an increase in 
LDH release in either control or CoMTb stimulated cells. 
 
Figure S2.  DMOG up-regulates MMP-9 secretion in NHBE cells stimulated with CoMTb.  
NHBE cells were pre-incubated with DMOG (0.25mM) for 2 hours before stimulation with 
CoMTb.  Supernatants were harvested at 72 hours.   (A)  Gelatin zymography shows DMOG 
increases MMP-9 gelatinolytic activity compared to control cells.  A marked increase in 
MMP-9 proteolytic activity is seen in CoMTb stimulated cells.  (B) DMOG and CoMTb 
stimulation increases MMP-9 secretion compared to cells treated with DMOG or CoMTb 
alone.  *p<0.05 
 
Figure S3.  Hypoxia and DMOG up-regulates MMP-1 secretion in A549 cells stimulated 
with CoMTb.  
A549 cells were incubated in hypoxia (pO2 1%) or pre-incubated with DMOG (0.25mM) for 2 
hours and then stimulated with CoMTb.  Supernatants were harvested at 72 hours and 
MMP-1 concentrations measured by ELISA.  (A) Hypoxia significantly increases MMP-1 
secretions compared to cells incubated in normoxia.   (B) DMOG significantly up-regulates 
MMP-1 secretion compared to cells treated with DMOG or CoMTb alone.  ***p<0.001 
 
